Lewisville, Texas-based orthopedic medical device company Orthofix Medical, Inc. and surgical imaging and guidance system company nView Medical have announced a partnership. The two companies have entered into an investment agreement with intent to develop and market correctional procedure solutions and technology for cervical spine issues and pediatric limb deformities.
Orthofix Partners With nView Medical
2 min read Premium comments
Secondary#orthofixmedical#insta3dtechnology#nviews1system
“The nView s1 system’s insta-3D imaging technology complements Orthofix’s pre-planning and post-operative software platforms. It is an innovative digital solution aimed at better streamlining the surgery by reducing radiation exposure and decreasing OR time, which is so important for pediatric surgeons and their patients,” said Jon Serbousek, Orthofix president and CEO. “We also look forward to working with nView to expand application of this technology for use in cervical spine procedures, utilizing Orthofix cervical solutions.”
Orthofix Medical’s mission is to “deliver innovative, quality-driven solutions while partnering with health care professionals to improve patient mobility.” The company’s technology has an international reach. Orthofix spinal products are distributed in over 60 countries. It is currently the 8th largest orthopedic device company on the planet.
Based in Salt Lake City, nView Medical aims to improve orthosurgical safety and accuracy through imaging and guidance system technologies that utilize artificial intelligence (AI). The company’s use of AI imagery and visualization to aid surgeons is innovative and combined with Orthofix technology will enable new, cutting edge orthopedic solutions. Medical backers for the company include the National Institutes of Health (NIH), the National Science Foundation (NSF), National Consortium for Pediatric Device Innovation, HealthTech Arkansas, MedTech Innovator, Fusion Fund, and the National Consortium for Pediatric Device Innovation.
The nView s1™ system with insta-3D™ technology has the novel capability to capture 3D images in real time via the use of low-dose radiation. This provides a live, GPS-like surgical AI guidance system for orthosurgical use. The partnership between the medtech companies will allow Orthofix to utilize nView s1 imaging and navigation system in Lewisville for training surgeon customers.
“We are very excited to partner with Orthofix, who has a long history in pediatric limb deformity correction, and deep expertise with adult cervical spine procedures,” said Cristian Atria, nView Medical founder and CEO. “As we continue the initial commercial rollout of our technology in pediatrics, we look forward to bringing our value proposition to more patients and surgeons, who are also served by Orthofix.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.